Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell Re-Directing Bispecific Antibodies

INDIANAPOLIS and UTRECHT, The Netherlands, Jan. 19, 2021 -- (Healthcare Sales & Marketing Network) -- Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company (NYSE: LLY), and Merus N.V. (NASDAQ: MRUS), a clinical-stage oncology c... Biopharmaceuticals, Oncology Eli Lilly, Loxo Oncology, Merus NV
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news